Loading…
Emmons Livestock, a cattle dealing operation, was cited for selling an adulterated animal for human consumption after failing to verify the medication status of cattle in their care. During inspections in August and September 2022, the FDA found that a cow sold for slaughter in December 2021 contained drug residues—florfenicol at 6.70 ppm (exceeding the 3.7 ppm tolerance) and tilmicosin at 1.52 ppm (exceeding the 1.2 ppm tolerance)—in liver tissue, violating the Federal Food, Drug, and Cosmetic Act. The company did not respond to the FDA's Inspectional Observations form listing these violations.